BMS is an American pharma company which specialises in cancer, HIV/AIDS and cardiovascular drugs, among others.
It has its headquarters in New York and offices all over the world, including its UK base in the Wirral.
Revenues for the company last year were in excess of $26bn.
Dhanda (right) joins BMS from rival pharma firm Pfizer, where he worked in policy and public affairs for the company’s rare diseases products.
He began his comms career at Birmingham-based equality charity Brap, where he rose to become its policy director.
Dhanda moved to Macmillan Cancer Support, where he stayed for ten years, rising to become the head of its policy & impact directorate.
Dhanda has also worked in public sector health, as head of strategic relationship management for NHS Digital, before moving to Pfizer.
Commenting on his new appointment, Rachel Royall, Dhanda's former boss as director of comms at NHS Digital, told PRWeeek: "Jagtar is a great colleague. He has a great strategic mind, is passionate about transforming healthcare and is a fabulous team player. I wish him the best of luck in his new role."
Click here to subscribe to the FREE pharma and healthcare comms bulletin to receive dedicated healthcare news, features and comment straight to your inbox.
Make sure you register for the site to access more than one story per month.
To submit a news, comment, case study or analysis idea for the pharma and healthcare comms bulletin, email Ian.Griggs@haymarket.com